Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium wilfordii tablets for active ankylosing spondylitis
ChiCTR-TRC-11001193Phase 4Completed
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jan 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tripterygium wilfordii in ankylosing spondylitis (AS) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: IgA, liver function and 3 more. Started Jan 2011; status: completed.
02
Drugs
Tripterygium wilfordii
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on ChiCTR-TRC-11001193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001193.